Download PDF (external access)

Human Genetics

Publication date: 2000-03-01
Volume: 106 Pages: 259 - 268
Publisher: Springer verlag

Author:

Dork, T
Macek, M ; Mekus, F ; Tummler, B ; Tzountzouris, J ; Casals, T ; Krebsova, A ; Koudova, M ; Sakmaryova, I ; Macek, M ; Vavrova, V ; Zemkova, D ; Ginter, E ; Petrova, NV ; Ivaschenko, T ; Baranov, V ; Witt, M ; Pogorzelski, A ; Bal, J ; Zekanowsky, C ; Wagner, K ; Stuhrmann, M ; Bauer, I ; Seydewitz, HH ; Neumann, T ; Jakubiczka, S ; Kraus, C ; Thamm, B ; Nechiporenko, M ; Livshits, L ; Mosse, N ; Tsukerman, G ; Kadasi, L ; Ravnik-Glavac, M ; Glavac, D ; Komel, R ; Vouk, K ; Kucinskas, V ; Krumina, A ; Teder, M ; Kocheva, S ; Efremov, GD ; Onay, T ; Kirdar, B ; Malone, G ; Schwarz, M ; Zhou, ZQ ; Friedman, KJ ; Carles, S ; Claustres, M ; Bozon, D ; Verlingue, C ; Ferec, C ; Tzetis, M ; Kanavakis, E ; Cuppens, Harry ; Bombieri, C ; Pignatti, PF ; Sangiuolo, F ; Jordanova, A ; Kusic, J ; Radojkovic, D ; Sertic, J ; Richter, D ; Rukavina, AS ; Bjorck, E ; Strandvik, B ; Cardoso, H ; Montgomery, M ; Nakielna, B ; Hughes, D ; Estivill, X ; Aznarez, I ; Tullis, E ; Tsui, LC ; Zielenski, J

Keywords:

transmembrane conductance regulator, identification, alleles, dna, recombination, heterogeneity, population, 90-percent, sequence, absence, Science & Technology, Life Sciences & Biomedicine, Genetics & Heredity, TRANSMEMBRANE CONDUCTANCE REGULATOR, IDENTIFICATION, ALLELES, DNA, RECOMBINATION, HETEROGENEITY, POPULATION, 90-PERCENT, SEQUENCE, ABSENCE, Alleles, Child, Child, Preschool, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, DNA Mutational Analysis, Europe, Female, Gene Frequency, Humans, Infant, Infant, Newborn, Male, Phenotype, Reverse Transcriptase Polymerase Chain Reaction, Sequence Deletion, 0604 Genetics, 1104 Complementary and Alternative Medicine, 1114 Paediatrics and Reproductive Medicine, 3105 Genetics, 3215 Reproductive medicine

Abstract:

We report a large genomic deletion of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, viz.. a deletion that is frequently observed in Central and Eastern Europe. The mutation, termed CFTRdele2.3(21 kb), deletes 21,080 bp spanning introns 1-3 of the CFTR gene. Transcript analyses have revealed that this deletion results in the loss of exons 2 and 3 in epithelial CFTR mRNA, thereby producing a premature termination signal within exon 4. In order to develop a simple polymerase chain reaction assay for this allele, we defined the end-points of the deletion at the DNA sequence level. We next screened for this mutation in a representative set of European and European-derived populations. Some 197 CF patients, including seven homozygotes, bearing this mutation have been identified during the course of our study. Clinical evaluation of CFTRdele2.3(21 kb) homozygotes and a comparison of compound heterozygotes for Delta F508/CFTRdele2,3(21 kb) with pairwise-matched Delta F508 homozygotes indicate that this deletion represents a severe mutation associated with pancreatic insufficiency and early age at diagnosis. Current data show that the mutation is particularly common in Czech (6.4% of all CF chromosomes), Russian (5.2%), Belorussian (3.3%). Austrian (2.6%), German (1.5%), Polish (1.5%), Slovenian (1.5%), Ukrainian (1.2%), and Slovak patients (1.1%). It has also been found in Lithuania, Latvia, Macedonia and Greece and has sporadically been observed in Canada, USA, France, Spain, Turkey, and UK, but not in CF patients from Bulgaria, Croatia, Romania or Serbia. Haplotype analysis has identified the same extragenic CF-haplotype: XV-2c/KM. 19 "A" and the same infrequent intragenic microsatellite haplotype 16-33-13 (IVS8CA-IVS17bTA-IVSI7bCA) in all examined CFTRdele2,3(21 kb) chromosomes, suggesting a common origin for this deletion. We conclude that the 21-kb deletion is a frequent and severe CF mutation in populations of Eastern- and Western-Slavic descent.